bioequivalence study of two closantel formulations in sheep

نویسندگان

حسینعلی عرب

مریم جاهدی نیا

علی رسولی

غلامرضا شمس

چکیده

bioequivalence study is a scientific and practical method used to compare the quality of a generic drug with a reference product. this study aimed to examine the bioequivalence of two closantel formulations produced with different sources of raw material by a domestic pharmaceutical company. due to long half- life of closantel, the study carried out by a parallel method. thirty sheep were divided into 2 groups of 15 each. in the first group (test group) each sheep received 500 mg bolus of closantel and in the second group (reference group), each sheep received a 500 mg bolus of closantel produced with a raw material from a belgium company. blood samples were collected at 0, 4, 8, 12, 16, 20, 24, 32, 48 and 72 hours after drug administration. an hplc system was used to determine the amount of closantel in plasma. pharmacokinetic parameters including area under curve (auc), cmax, tmax, kel and t1/2 of closantel were determined in each sheep. a t-student test was used to analyze and compare the results. the mean ± sd of cmax in reference and test groups were 56.38±14.28 µg/ml, 51.44±10.55, respectively. tmax in reference and test groups were 22.93± 2.81, 23.72± 1.83 h, respectively . auc (0-72) in reference and test drugs were 2049.1±421.2 and, 1795.1± 421.2, respectively. auc (0-||•||) in reference and test were 2557.3±621.5 and 2171.1± 80. kel in reference group was 0.0321± 0.0144 while in test it was 0.0348± 0.0128. t1/2 in reference and test groups were 24.85± 8.34 h and, 22.29± 8.03 h, respectively. in conclusion, the results of this study showed that there was not significant difference between reference and test group, suggesting that two products were bioequivalent.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pharmacokinetics and Bioequivalence study of Two Formulations of Cefixime in Healthy Male Volunteers

Cefixime is a significant member of orally active third generation cephalosporin and has excellent activity against many pathogens. The virtual bioavailability of a newly industrial dispersible tablet as compared with a recognized identified formulation. An open-label, single-dose, randomized, 2-way crossover study was conducted in fasted healthy Iranian male volunteers. Eligible participa...

متن کامل

Bioequivalence Study of Two Formulations of Tramadol Capsules in Healthy Myanmar Volunteers

Background: Tramadol is one of the most commonly used analgesics, thanks to its efficacy and safety. It is widely used in Myanmar for postoperative and cancer pain control. The use of generic drugs has been steadily increasing worldwide, mostly in developing countries. Generic drugs should have efficacy and safety comparable to their innovators or other approved generic products.  Objectives: ...

متن کامل

Bioequivalence assessment of two formulations of ibuprofen

BACKGROUND This study assessed the relative bioavailability of two formulations of ibuprofen. The first formulation was Doloraz(®), produced by Al-Razi Pharmaceutical Company, Amman, Jordan. The second forumulation was Brufen(®), manufactured by Boots Company, Nottingham, UK. METHODS AND RESULTS A prestudy validation of ibuprofen demonstrated long-term stability, freeze-thaw stability, precis...

متن کامل

Bioequivalence Studies of Two Formulations of Baclofen Tablet in Healthy Volunteers

The relative bioavailability of the test (generic) product 2 × 25 mg baclofen tablets, with respect to the reference product, Lioresal® 2 × 25 mg tablets (baclofen; Squibb) was determined in a single-blind, single dose, randomised, crossover study. The mean values for the variable Cmax were 737.6 ng/ml for the reference and 739.5 ng/ml for the test product. The mean values for the variable AUC ...

متن کامل

Bioequivalence Studies of Two Formulations of Baclofen Tablet in Healthy Volunteers

The relative bioavailability of the test (generic) product 2 × 25 mg baclofen tablets, with respect to the reference product, Lioresal® 2 × 25 mg tablets (baclofen; Squibb) was determined in a single-blind, single dose, randomised, crossover study. The mean values for the variable Cmax were 737.6 ng/ml for the reference and 739.5 ng/ml for the test product. The mean values for the variable AUC ...

متن کامل

Metabolite Parameters as an Appropriate Alternative Approach for Assessment of Bioequivalence of Two Verapamil Formulations

A bioequivalence study of two verapamil formulations (generic verapamil tablets and Isoptin® tablets) was performed by comparing pharmacokinetic parameters of the parent drug and its major metabolite, norverapamil following a single dose administration of 80 mg verapamil hydrochloride in 22 healthy volunteers according to a randomized, two-period, crossover-design study. Moreover, the feasibili...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
تحقیقات دامپزشکی

جلد ۶۵، شماره ۳، صفحات ۰-۰

کلمات کلیدی
[ ' b i o e q u i v a l e n c e s t u d y i s a s c i e n t i f i c a n d p r a c t i c a l m e t h o d u s e d t o c o m p a r e t h e q u a l i t y o f a g e n e r i c d r u g w i t h a r e f e r e n c e p r o d u c t . t h i s s t u d y a i m e d t o e x a m i n e t h e b i o e q u i v a l e n c e o f t w o c l o s a n t e l f o r m u l a t i o n s p r o d u c e d w i t h d i f f e r e n t s o u r c e s o f r a w m a t e r i a l b y a d o m e s t i c p h a r m a c e u t i c a l c o m p a n y . d u e t o l o n g h a l f ' , ' l i f e o f c l o s a n t e l ' , ' t h e s t u d y c a r r i e d o u t b y a p a r a l l e l m e t h o d . t h i r t y s h e e p w e r e d i v i d e d i n t o 2 g r o u p s o f 1 5 e a c h . i n t h e f i r s t g r o u p ( t e s t g r o u p ) e a c h s h e e p r e c e i v e d 5 0 0 m g b o l u s o f c l o s a n t e l a n d i n t h e s e c o n d g r o u p ( r e f e r e n c e g r o u p ) ' , ' e a c h s h e e p r e c e i v e d a 5 0 0 m g b o l u s o f c l o s a n t e l p r o d u c e d w i t h a r a w m a t e r i a l f r o m a b e l g i u m c o m p a n y . b l o o d s a m p l e s w e r e c o l l e c t e d a t 0 ' , 4 , 8 , 1 2 , 1 6 , 2 0 , 2 4 , 3 2 , ' 4 8 a n d 7 2 h o u r s a f t e r d r u g a d m i n i s t r a t i o n . a n h p l c s y s t e m w a s u s e d t o d e t e r m i n e t h e a m o u n t o f c l o s a n t e l i n p l a s m a . p h a r m a c o k i n e t i c p a r a m e t e r s i n c l u d i n g a r e a u n d e r c u r v e ( a u c ) ' , ' c m a x ' , ' t m a x ' , ' k e l a n d t 1 / 2 o f c l o s a n t e l w e r e d e t e r m i n e d i n e a c h s h e e p . a t ' , ' s t u d e n t t e s t w a s u s e d t o a n a l y z e a n d c o m p a r e t h e r e s u l t s . t h e m e a n ± s d o f c m a x i n r e f e r e n c e a n d t e s t g r o u p s w e r e 5 6 . 3 8 ± 1 4 . 2 8 µ g / m l ' , ' 5 1 . 4 4 ± 1 0 . 5 5 ' , ' r e s p e c t i v e l y . t m a x i n r e f e r e n c e a n d t e s t g r o u p s w e r e 2 2 . 9 3 ± 2 . 8 1 ' , ' 2 3 . 7 2 ± 1 . 8 3 h ' , ' r e s p e c t i v e l y . a u c ( 0 ' , ' 7 2 ) i n r e f e r e n c e a n d t e s t d r u g s w e r e 2 0 4 9 . 1 ± 4 2 1 . 2 a n d ' , ' 1 7 9 5 . 1 ± 4 2 1 . 2 ' , ' r e s p e c t i v e l y . a u c ( 0 ' , ' | | | | ) i n r e f e r e n c e a n d t e s t w e r e 2 5 5 7 . 3 ± 6 2 1 . 5 a n d 2 1 7 1 . 1 ± 8 0 . k e l i n r e f e r e n c e g r o u p w a s 0 . 0 3 2 1 ± 0 . 0 1 4 4 w h i l e i n t e s t i t w a s 0 . 0 3 4 8 ± 0 . 0 1 2 8 . t 1 / 2 i n r e f e r e n c e a n d t e s t g r o u p s w e r e 2 4 . 8 5 ± 8 . 3 4 h a n d ' , ' 2 2 . 2 9 ± 8 . 0 3 h ' , ' r e s p e c t i v e l y . i n c o n c l u s i o n ' , ' t h e r e s u l t s o f t h i s s t u d y s h o w e d t h a t t h e r e w a s n o t s i g n i f i c a n t d i f f e r e n c e b e t w e e n r e f e r e n c e a n d t e s t g r o u p ' , ' s u g g e s t i n g t h a t t w o p r o d u c t s w e r e b i o e q u i v a l e n t . ' ]

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023